VAERS Explorer
Back to explore

Report #2866101

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

Product administered to patient of inappropriate ageProduct prescribing error

Symptom narrative

Under 50, but doctor recommended Shingrix; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug prescribing error in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug prescribing error (Verbatim: Under 50, but doctor recommended Shingrix). The outcome of the drug prescribing error was not applicable. Additional Information: GSK Receipt Date: 25-SEP-2025 This case was reported by a patient via interactive digital media. The physician recommended Shingrix for the patient who was below 50 years of age. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2025AMR124610:Original Case Number : US2025AMR124581 US-GSK-US2025AMR124609:Original Case Number : US2025AMR124581 US-GSK-US2025AMR124608:Original Case Number : US2025AMR124581 US-GSK-US2025AMR124581:Original Case Number : US2025AMR124581 US-GSK-US2025AMR124607:Original Case Number : US2025AMR124581